イリノイ州における膀胱癌の臨床試験
イリノイ州内の拠点で、膀胱癌に関する30件の研究が参加者を募集しています。
イリノイ州内の都市
- Chicago21件の研究
- Cicero8件の研究
- Joliet7件の研究
- Evanston7件の研究
- Springfield6件の研究
- Decatur6件の研究
- Champaign4件の研究
- Charleston4件の研究
- Danville4件の研究
- Naperville4件の研究
- Peoria4件の研究
- Bloomington4件の研究
- Arlington Heights3件の研究
- Aurora3件の研究
- Waukegan3件の研究
- North Peoria3件の研究
- Galesburg3件の研究
公式研究テキスト（英語）
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Rush-Copley Medical Center, Aurora
- OSF Saint Joseph Medical Center, Bloomington
- Illinois CancerCare-Bloomington, Bloomington
- 他38件
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07061964A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- University of Illinois Cancer Center, Chicago
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Associated Urological Specialists - Chicago Ridge ( Site 0139), Chicago Ridge
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06833073Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Rush MD Anderson Cancer Center, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Carle at The Riverfront, Danville
- 他12件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Hope and Healing Clinical Research LLC, Hinsdale
- Hope and Healing Clinical Research LLC, New Lenox
- Illinois Cancer Specialists, Niles
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07566156Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Rush MD Anderson Cancer Center, Chicago
- Carle at The Riverfront, Danville
- Cancer Care Specialists of Illinois - Decatur, Decatur
- 他11件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06770582Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Memorial Hospital, Shiloh
- Siteman Cancer Center - Shiloh, Shiloh
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07421700A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- City of Hope Cancer Center-Chicago, Zion
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Northwestern Memorial Hospital, Chicago
- Northwestern University - Feinberg School of Medicine, Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07206225A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- University of Illinois at Chicago, Chicago
- University of Chicago Medical Center, Chicago
- Endeavor Health, Evanston
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University of Chicago Hospital, Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06465069Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Associated Urological Specialists, Chicago Ridge
- Uropartners, Glenview
- Accellacare, Lisle
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06567743Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- 他54件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/09/02更新 · NCT05334069KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
- University of Chicago Medical Center ( Site 5037), Chicago
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/01更新 · NCT07232602Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Comprehensive Urologic Care, Lake Barrington
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/24更新 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- The University of Chicago Medical Center (UCMC), Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05614739Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
- Research Site, Niles
- Research Site, Peoria
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/20更新 · NCT07129993Measuring Surgical Recovery After Radical Cystectomy
- University of Chicago, Chicago
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/19更新 · NCT03193970Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- OSF Saint Anthony's Health Center, Alton
- OSF Saint Joseph Medical Center, Bloomington
- Illinois CancerCare-Bloomington, Bloomington
- 他32件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07097142Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Northwestern University, Chicago
- University of Illinois, Chicago
- Loyola University Medical Center, Maywood
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/05更新 · NCT07000084A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- UChicago Medicine - River East, Chicago
- University of Chicago Medical Center, Chicago
- Accellacare - Deerfield, Deerfield
- 他5件
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/22更新 · NCT04879329A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Ingalls Family Care Center, Calumet City
- UChicago Medicine - River East, Chicago
- The University Of Chicago, Chicago
- 他13件
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
- Northwestern University, Chicago
- Northwestern Medicine Orland Park, Orland Park
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06630416A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- The University of Chicago Comprehensive Cancer Center, Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT06778863Blue Light Cystoscopy With Cysview® Registry
- Northwestern University, Chicago
- Northshore University Health System, Evanston
被験者募集中観察研究
18歳以上 · 全性別 · 2025/12/18更新 · NCT02660645SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chicago
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
- Jesse Brown Department Of Veterans Affairs Medical Center, Chicago
被験者募集中観察研究
18歳〜100歳 · 全性別 · 2025/10/10更新 · NCT06310759Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
被験者募集中
65歳以上 · 全性別 · 2025/10/03更新 · NCT06427824ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。